Feb 25, 2021 / 06:00PM GMT
Danielle Joy Antalffy - SVB Leerink LLC, Research Division - MD of Medical Supplies and Devices & Senior Analyst
Good afternoon, everyone. Thanks so much for joining us for our Annual SVB Leerink Global Healthcare Conference. We are very lucky to have with us today, Edwards' CFO, Scott Ullem. I believe, also Head of IR, Mark Wilterding, is on the line as well. So Scott, thank you so much for being here.
Scott B. Ullem - Edwards Lifesciences Corporation - Corporate VP & CFO
It's my pleasure. Good to see you, Danielle, and thanks, everyone, for your interest in Edwards.
Questions and Answers:
Danielle Joy Antalffy - SVB Leerink LLC, Research Division - MD of Medical Supplies and Devices & Senior AnalystSo Scott, maybe a good place to start. It's been a few weeks Edwards reported Q4 earnings and provided, actually, reiterated 2021 guidance. Maybe give us a quick snapshot of where we are today or as of the end of Q4 with Edwards. And then obviously, I'm going to press you on how things may or may not
Trustpilot
